Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 2461 AL 2475

Shared and disease-specific human brain vascular signatures in Alzheimer's disease, frontotemporal dementia, and Huntington's disease

Forster PM, Bracko O, Rust R.

bioRxiv [Preprint]. 2026 Jul 3:2026.07.01.735865. doi: 10.64898/2026.07.01.735865.

Precision Medicine in Neurodegeneration with Brain Iron Accumulation (NBIA) Disorders: An Update on Emerging Treatments

Schneider SA, Garg D, Iankova V, Klopstock T.

Mov Disord Clin Pract. 2026 Oct;13(10):2405-2418. doi: 10.1002/mdc3.70736. Epub 2026 Jul 10.

The Role of PGC-1α in Neurodegenerative Diseases: Molecular Mechanisms, Translational Challenges, and Therapeutic Potential

You Y, Duan D, Xiang Q.

Mol Neurobiol. 2026 Jul 10;63(1):755. doi: 10.1007/s12035-026-06029-x.

Glymphatic dysfunction in neurodegeneration: From impaired clearance to mechanism-driven therapeutic innovation

Kalra P, Grewal AK.

Curr Opin Pharmacol. 2026 Aug;89:102647. doi: 10.1016/j.coph.2026.102647. Epub 2026 Jun 19.

The role of AI-assisted drug repurposing in neurological disorders: a systematic review of validation strategies, challenges and opportunities

Chen F, Wang L, Liu H, Khan Q, Tang B, Bao N.

J Nanobiotechnology. 2026 Jul 10;24(1):790. doi: 10.1186/s12951-026-04551-7.

Gangliosides in the 21st century: therapeutic prospects for the brain and spine

Magistretti PJ, Finsterwald C, Itokazu Y, Sipione S, Geisler FH, Filho TB.

Front Neurol. 2026 Jun 15;17:1795901. doi: 10.3389/fneur.2026.1795901. eCollection 2026.

Precision therapeutics and innovative clinical trial design in neurodegenerative diseases

Domínguez-García A, Delgado-Uriarte JC, Cervantes-Arriaga A.

Rev Invest Clin. 2026 Jul-Aug;78(4):100050. doi: 10.1016/j.ric.2026.100050. Epub 2026 Jul 11.

Targeting DNA mismatch repair in Huntington's disease

Bunting EL, Panhale A, McColgan P, Koi M, Brundin P, Carethers JM.

Trends Neurosci. 2026 Jul 11:S0166-2236(26)00120-7. doi: 10.1016/j.tins.2026.06.004. Online ahead of print.

When Benign Isn't So Benign: "Status Choreatus" in Benign Hereditary Chorea Challenging the Norm

Farsana MK, Holla VV, Kamble N, Arunachal G, Yadav R, Pal PK.

Mov Disord Clin Pract. 2026 Jul 12:10.1002/mdc3.70724. doi: 10.1002/mdc3.70724. Online ahead of print.

The nano-intervention in Huntington's disease: A theragnostic approach

Kumar A, Dewangan JP, Kumar S, Parveen S, Sahebkar A, Kesharwani P, Shukla R.

Neuroscience. 2026 Sep 28;612:1-15. doi: 10.1016/j.neuroscience.2026.07.022. Epub 2026 Jul 13.

Astrocytic lipid dysregulation as an early driver of neurodegeneration

Kim WS, Halliday GM.

Nat Rev Neurol. 2026 Aug;22(8):485-497. doi: 10.1038/s41582-026-01238-3. Epub 2026 Jul 13.

Practical recommendations for the treatment of chorea associated with Huntington's disease: An expert consensus

Furr Stimming E, Bang J, Brown A, Bulica B, Frank S, Houghton D, McFarland NR, Mestre TA, Aradi S, Sung V, Claassen D.

J Huntingtons Dis. 2026 Jul 14:18796397261468482. doi: 10.1177/18796397261468482. Online ahead of print.

Understanding the cellular architecture of Huntington's disease

Pustina D.

Elife. 2026 Jul 14;15:e112225. doi: 10.7554/eLife.112225.

Actin nucleation promoting factors drive Arp2/3 dependent endosomal microautophagy

Surabhi S, Jenny A.

bioRxiv [Preprint]. 2026 Jul 10:2026.07.09.737473. doi: 10.64898/2026.07.09.737473.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias